174 related articles for article (PubMed ID: 27616598)
1. Antinuclear autoantibodies and pregnancy outcome in women with unexplained recurrent miscarriage.
Ticconi C; Pietropolli A; Borelli B; Bruno V; Piccione E; Bernardini S; Di Simone N
Am J Reprod Immunol; 2016 Nov; 76(5):396-399. PubMed ID: 27616598
[TBL] [Abstract][Full Text] [Related]
2. Antinuclear antibodies in women with recurrent pregnancy wastage and their prognostic value for immunotherapy.
Malinowski A; Szpakowski M; Wilczyński J; Oszukowski P; Puchała B; Włodarczyk B
Zentralbl Gynakol; 1994; 116(11):631-5. PubMed ID: 7871915
[TBL] [Abstract][Full Text] [Related]
3. Antinuclear Antibodies predict a higher number of Pregnancy Loss in Unexplained Recurrent Pregnancy Loss.
Sakthiswary R; Rajalingam S; Norazman MR; Hussein H
Clin Ter; 2015; 166(2):e98-101. PubMed ID: 25945451
[TBL] [Abstract][Full Text] [Related]
4. Antinuclear autoantibodies in women with recurrent pregnancy loss.
Ticconi C; Rotondi F; Veglia M; Pietropolli A; Bernardini S; Ria F; Caruso A; Di Simone N
Am J Reprod Immunol; 2010 Dec; 64(6):384-92. PubMed ID: 20482520
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of autoantibodies in patients with recurrent miscarriages.
Ogasawara M; Aoki K; Katano K; Aoyama T; Kajiura S; Suzumori K
Am J Reprod Immunol; 1999 Jan; 41(1):86-90. PubMed ID: 10097791
[TBL] [Abstract][Full Text] [Related]
6. Uterine and placental blood flow indexes and antinuclear autoantibodies in unexplained recurrent pregnancy loss: should they be investigated in pregnancy as correlated potential factors? A retrospective study.
Bruno V; Ticconi C; Martelli F; Nuccetelli M; Capogna MV; Sorge R; Piccione E; Pietropolli A
BMC Pregnancy Childbirth; 2020 Jan; 20(1):44. PubMed ID: 31959152
[TBL] [Abstract][Full Text] [Related]
7. Recurrent miscarriage is associated with increased numbers of CD5/20 positive lymphocytes and an increased incidence of thyroid antibodies.
Roberts J; Jenkins C; Wilson R; Pearson C; Franklin IA; MacLean MA; McKillop JH; Walker JJ
Eur J Endocrinol; 1996 Jan; 134(1):84-6. PubMed ID: 8590962
[TBL] [Abstract][Full Text] [Related]
8. Uterine blood flow indices, antinuclear autoantibodies and unexplained recurrent miscarriage.
Pietropolli A; Bruno V; Capogna MV; Bernardini S; Piccione E; Ticconi C
Obstet Gynecol Sci; 2015 Nov; 58(6):453-60. PubMed ID: 26623408
[TBL] [Abstract][Full Text] [Related]
9. Studies on associations between human leukocyte antigen (HLA) class II alleles and antiphospholipid antibodies in Danish and Czech women with recurrent miscarriages.
Christiansen OB; Ulcova-Gallova Z; Mohapeloa H; Krauz V
Hum Reprod; 1998 Dec; 13(12):3326-31. PubMed ID: 9886508
[TBL] [Abstract][Full Text] [Related]
10. Non-visualized pregnancy losses are prognostically important for unexplained recurrent miscarriage.
Kolte AM; van Oppenraaij RH; Quenby S; Farquharson RG; Stephenson M; Goddijn M; Christiansen OB;
Hum Reprod; 2014 May; 29(5):931-7. PubMed ID: 24603132
[TBL] [Abstract][Full Text] [Related]
11. Significance of antinuclear antibody testing in unexplained second and third trimester fetal deaths.
Incerpi MH; Banks EH; Goodwein SN; Samadi R; Goodwin TM
J Matern Fetal Med; 1998; 7(2):61-4. PubMed ID: 9584815
[TBL] [Abstract][Full Text] [Related]
12. [Antinuclear antibody measurement as a screening test for sterile and infertile women with immunological abnormality].
Nakatsuka M; Yoshida N; Hasegawa A; Nishikori K; Hirano Y; Katayama T; Shintani K; Noma J; Shimizu K; Kudo T
Nihon Sanka Fujinka Gakkai Zasshi; 1993 May; 45(5):431-6. PubMed ID: 8496633
[TBL] [Abstract][Full Text] [Related]
13. Antinuclear antibodies and recurrent miscarriage: Systematic review and meta-analysis.
Cavalcante MB; Cavalcante CTMB; Sarno M; da Silva ACB; Barini R
Am J Reprod Immunol; 2020 Mar; 83(3):e13215. PubMed ID: 31821640
[TBL] [Abstract][Full Text] [Related]
14. Thyroid peroxidase antibody in women with unexplained recurrent miscarriage: prevalence, prognostic value, and response to empirical thyroxine therapy.
Yan J; Sripada S; Saravelos SH; Chen ZJ; Egner W; Li TC
Fertil Steril; 2012 Aug; 98(2):378-82. PubMed ID: 22624672
[TBL] [Abstract][Full Text] [Related]
15. Risk factors associated with a new pregnancy loss and perinatal outcomes in cases of recurrent miscarriage treated with lymphocyte immunotherapy.
Cavalcante MB; Costa Fda S; Araujo Júnior E; Barini R
J Matern Fetal Neonatal Med; 2015 Jun; 28(9):1082-6. PubMed ID: 25005857
[TBL] [Abstract][Full Text] [Related]
16. Natural killer cell activity in women with recurrent miscarriage: Etiology and pregnancy outcome.
Ebina Y; Nishino Y; Deguchi M; Maesawa Y; Nakashima Y; Yamada H
J Reprod Immunol; 2017 Apr; 120():42-47. PubMed ID: 28441552
[TBL] [Abstract][Full Text] [Related]
17. Antinuclear and antiphospholipid antibodies in healthy women with recurrent spontaneous abortion.
Eroglu GE; Scopelitis E
Am J Reprod Immunol; 1994 Jan; 31(1):1-6. PubMed ID: 8166942
[TBL] [Abstract][Full Text] [Related]
18. Thyroid antibody titer and avidity in patients with recurrent miscarriage.
Wilson R; Ling H; MacLean MA; Mooney J; Kinnane D; McKillop JH; Walker JJ
Fertil Steril; 1999 Mar; 71(3):558-61. PubMed ID: 10065798
[TBL] [Abstract][Full Text] [Related]
19. Antinuclear antibodies positivity is a risk factor of recurrent pregnancy loss: A meta-analysis.
Chen S; Yang G; Wu P; Sun Y; Dai F; He Y; Qian H; Liu Y; Shi G
Semin Arthritis Rheum; 2020 Aug; 50(4):534-543. PubMed ID: 32442739
[TBL] [Abstract][Full Text] [Related]
20. Future pregnancy outcome in unexplained recurrent first trimester miscarriage.
Clifford K; Rai R; Regan L
Hum Reprod; 1997 Feb; 12(2):387-9. PubMed ID: 9070732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
